P
11.97
0.10 (0.84%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Phathom Pharmaceuticals, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
-0.1
| 分析师共识 | 2.0 |
| 内部交易活动 | 0.0 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.10 |
|
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 4.28% |
| 机构持股比例 | 84.77% |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| COLA MICHAEL F | 11.40 | - | 24,122 | 274,991 |
| FIELDS HEIDI | 11.40 | - | 24,122 | 274,991 |
| KARBE FRANK | 11.40 | - | 24,122 | 274,991 |
| PARIKH ASIT | 11.37 | 11.33 | 24,122 | 274,991 |
| SCHROEDER THEODORE R | 11.40 | - | 24,122 | 274,991 |
| STENHOUSE MARK | 11.40 | - | 24,122 | 274,991 |
| TOPPER JAMES N | 11.40 | - | 24,122 | 274,991 |
| 累积净数量 | 168,854 | |||
| 累积净值 ($) | 1,924,936 | |||
| 累积平均购买 ($) | 11.39 | |||
| 累积平均卖出 ($) | 11.33 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| PARIKH ASIT | 董事 | 22 May 2026 | 处理 (-) | 28,000 | 11.33 | 317,240 |
| PARIKH ASIT | 董事 | 22 May 2026 | 获得 (+) | 28,000 | 11.33 | 317,240 |
| PARIKH ASIT | 董事 | 20 May 2026 | 执行期权 | 17,500 | - | - |
| COLA MICHAEL F | 董事 | 19 May 2026 | 获得 (+) | 24,122 | 11.40 | 274,991 |
| KARBE FRANK | 董事 | 19 May 2026 | 获得 (+) | 24,122 | 11.40 | 274,991 |
| SCHROEDER THEODORE R | 董事 | 19 May 2026 | 获得 (+) | 24,122 | 11.40 | 274,991 |
| STENHOUSE MARK | 董事 | 19 May 2026 | 获得 (+) | 24,122 | 11.40 | 274,991 |
| TOPPER JAMES N | 董事 | 19 May 2026 | 获得 (+) | 24,122 | 11.40 | 274,991 |
| FIELDS HEIDI | 董事 | 19 May 2026 | 获得 (+) | 24,122 | 11.40 | 274,991 |
| PARIKH ASIT | 董事 | 19 May 2026 | 获得 (+) | 24,122 | 11.40 | 274,991 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合